Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

Merck & Co., Inc. (MRK) Profit Margins

Over the twelve months to 2026-06-30, Merck & Co., Inc. (MRK) had gross margin 73.0%, net margin 4.8%, free cash flow margin 24.1%, according to EquiReason's reading of its SEC filings.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

MRKMerck & Co., Inc.Follow MRK — free
Drug Manufacturers - General · Healthcare
—
Price chart with a free account
Market cap
358.4B
P/E TTM
115.3
Dividend yield
2.3%
52-week
—
Next earnings
29 Oct, in 5 days
LineFY2009
Dec 09
FY2010
Dec 10
FY2016
Dec 16
FY2017
Dec 17
FY2018
Dec 18
FY2019
Dec 19
FY2020
Dec 20
FY2021
Dec 21
FY2022
Dec 22
FY2023
Dec 23
FY2024
Dec 24
FY2025
Dec 25
TTM
Jun 26
Trend
Gross margin67.1%60.0%65.1%68.2%68.1%69.3%67.2%72.0%70.6%73.2%76.3%74.8%73.0%
Net margin47.0%1.9%9.8%6.0%14.7%25.2%17.0%26.8%24.5%0.6%26.7%28.1%4.8%
FCF margin7.0%19.9%22.0%11.4%19.6%25.7%14.0%17.8%24.8%15.2%28.2%19.0%24.1%

USD billions · SEC XBRL

Merck & Co., Inc. — questions

What is Merck & Co., Inc.'s gross margin?
73.0% over the twelve months to 2026-06-30.
What is Merck & Co., Inc.'s net profit margin?
4.8% over the twelve months to 2026-06-30.

Every figure on this page comes from Merck & Co., Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.